Medication past present and future in racing and performance horses
Download
1 / 14

Medication: Past - PowerPoint PPT Presentation


  • 642 Views
  • Uploaded on

Medication: Past, Present, and Future in Racing and Performance Horses. Scot Waterman, DVM Executive Director. Racing Medication & Testing Consortium. Began in 2001 at a facilitated meeting hosted by the AAEP to assess whether uniform medication rules were achievable

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Medication: Past' - daniel_millan


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Medication past present and future in racing and performance horses l.jpg

Medication: Past, Present, and Future in Racing and Performance Horses

Scot Waterman, DVM

Executive Director


Racing medication testing consortium l.jpg
Racing Medication & Testing Consortium Performance Horses

  • Began in 2001 at a facilitated meeting hosted by the AAEP to assess whether uniform medication rules were achievable

  • RMTC Goals: uniform rules, standardized testing, available money for research, improved security, information resource for racing commissions

  • Incorporated as a 501 c (3)


Board of directors l.jpg

AAEP Performance Horses

AQHA

Arabian Jockey Club

California TB Trainers

Churchill Downs

Del Mar

Hambletonian Society

Harness Tracks of America

The Jockey Club     

Jockeys’ Guild

Keeneland

KTA

Magna Entertainment

National HBPA

NTRA

NYRA

Oak Tree

RCI

THA

TOBA

TB Owners of California

TRA

TRPB

USTA

Board of Directors


Racing medication testing consortium4 l.jpg
Racing Medication & Testing Consortium Performance Horses

  • Diverse, large Board can be difficult but it ensures that no single agenda can drive the development of a rule, supermajority required for language to pass

  • Standard approach is to divide work up into sub-committees and bring the consensus back to the full Board

  • Language is either adopted by the Board, edited and then approved or sent back to the sub-committee


Veterinarian involvement in the rmtc l.jpg

Board members Performance Horses

Rick Arthur

(Oak Tree)

Nancy Goodman (AQHA)

Ted Hill

(The Jockey Club)

Bobby Lewis

(AAEP)

Gregg Scoggins

(MEC)

Ex officio

Glenn Blodgett (AQHA)

Ron Jensen (Advisor)

Milton McLure (AAEP)

Wayne McIlwraith (AAEP)

Committees

Tom Brokken

Gary Norwood

Dan Wilson

Tom Tobin

Mike Weber

Veterinarian involvement in the RMTC


Model rules phase 1 2005 l.jpg
Model Rules Phase 1 (2005) Performance Horses

  • Prohibited Practices

  • Drug Classifications/Categorization

  • Permitted Therapeutics:

    • Voluntary use of furosemide with post-race regulatory control

    • One of three NSAIDs – Bute, Banamine or Ketoprofen – at 24 hours

  • Adopted now by 32/38 racing jurisdictions


Uniform penalties 2006 l.jpg
Uniform Penalties (2006) Performance Horses

  • Three-tiered grid system simplified existing RCI penalties

  • Significantly increases penalties for illegal and prohibited performance-enhancing drugs

  • Reduces penalties for therapeutic medication mistakes

  • Redefines trainer responsibility

    • Mitigating and aggravating circumstances “checklist” for stewards

    • Added penalties for other culpable licensees: veterinarians, owners and grooms

  • Adopted as rule or policy in 25 states


Model rules phase 3 2007 l.jpg
Model Rules Phase 3 (2007) Performance Horses

  • Regulation of anabolic steroids

    • Thresholds for four FDA-permitted or endogenous anabolics

      • Stanozolol

      • Boldenone

      • Nandrolone

      • Testosterone

    • 30-45 days withdrawal time

  • Out-of-competition testing

    • Blood-doping agents – EPO & Darbypoietin

    • Illegal & prohibited drugs


Model rules present future withdrawal times research l.jpg
Model Rules-Present & Future Performance HorsesWithdrawal Times Research

  • Identify drugs with legitimate uses

  • Prioritize drugs into five groups

  • Collect previous science on each drug

  • If science is insufficient then perform administrations on a minimum of 20 horses

  • Plasma is preferred but some drugs will have both urine and plasma collected

  • Ultimate goal…uniform withdrawal time with a corresponding concentration of drug which regulates the withdrawal time


Withdrawal times research l.jpg

Priority Group 1 Performance Horses

Acepromazine

Butorphanol

Detomidine

Glycopyrrolate

Lidocaine

Mepivacaine

Methocarbamol

Pyrilamine

Priority Group 2

Boldenone

Dantrolene

Dexamethasone

Firocoxib

Fluphenazine

Hydroxyzine

Nandrolone

Stanozolol

Testosterone

Withdrawal Times Research


Withdrawal times research11 l.jpg

Priority Group 3 Performance Horses

Albuterol

Betamethasone

Diclofenac

Methylprednisolone

Reserpine

Triamcinolone

Trichlormethiazide

Xylazine

Priority Group 4

Atropine

Beclomethasone

Buscopan

Cromolyn

Isoxsuprine

Pentoxyfylline

Phenytoin

Prednisolone

Withdrawal Times Research


Model rules present future withdrawal time database l.jpg
Model Rules-Present & Future Withdrawal Time Database Performance Horses

  • Withdrawal times posted for 18 jurisdictions and over 70 drugs

  • Database is searchable by drug and by jurisdiction

  • Over 2,000 unique users in first month of availability

  • www.rmtcnet.com, click on “Withdrawal Times” tab at top of page


Rmtc present future drug testing initiatives l.jpg
RMTC-Present & Future Performance HorsesDrug Testing Initiatives

  • Develop strategies to improve drug testing in US:

    • Integrate WADA laboratory standards

    • Overhaul of Laboratory Quality Assurance Programs

    • Development of a post-doctoral recruitment program

    • Development of a business plan for U.S. drug testing infrastructure which includes research and development laboratory


Big picture the future l.jpg
Big picture…the future Performance Horses

  • Beginning to see organizations with “sticks” use them to drive change:

    • Thoroughbred Owners and Breeders Association Graded Stakes Committee

    • Breeder’s Cup

    • NTRA Safety Alliance

    • The Jockey Club Safety Committee

    • Hambletonian Society


ad